Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study

Affiliations

• ¹ Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome.
• ² Division of Hematology, Department of Translational Medicine, AOU Maggiore della Carità, Università del Piemonte Orientale, Novara.
• ³ Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy; AIL ROMA ODV, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome.
• ⁴ Hematology Department, ASST Settelaghi, Ospedale di Circolo - Fondazione Macchi, Varese.
• ⁵ Hematology Department, Azienda Ospedaliera Universitaria Senese, Siena.
• ⁶ San Raffaele Scientific Institute, Department of Onco-Hematology, Milan.
• ⁷ Division of Hematology and SCT, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), University Hospital of Udine.
• ⁸ Hematology Department, Ospedale Civile Pescara.
• ⁹ Hematology Department, Azienda Ospedaliero-Universitaria Careggi, Florence.
• ¹⁰ Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia.
• ¹¹ Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.
• ¹² Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Torino, Torino.
• ¹³ Hematology Department, Moscati Hospital, Aversa.
• ¹⁴ Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome. [email protected].